Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.
Article
Mehta, Minesh P, Gondi, Vinai, Ahluwalia, Manmeet Singh et al. (2024). Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.
. JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), 2008-2008. 10.1200/jco.2024.42.16_suppl.2008
Mehta, Minesh P, Gondi, Vinai, Ahluwalia, Manmeet Singh et al. (2024). Results from METIS (EF-25), an international, multicenter phase III randomized study evaluating the efficacy and safety of tumor treating fields (TTFields) therapy in NSCLC patients with brain metastases.
. JOURNAL OF CLINICAL ONCOLOGY, 42(16_suppl), 2008-2008. 10.1200/jco.2024.42.16_suppl.2008